Clonidine Hydrochloride Patent Expiration
Clonidine Hydrochloride was first introduced by Boehringer Ingelheim
Clonidine Hydrochloride Patents
Given below is the list of patents protecting Clonidine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Onyda Xr | US11918689 | Liquid clonidine extended release composition | Jul 28, 2041 | Tris Pharma Inc |
| Onyda Xr | US8062667 | Modified release formulations containing drug-ion exchange resin complexes | Mar 29, 2029 | Tris Pharma Inc |
| Jenloga | US5869100 | Extended release clonidine formulation (tablet) |
Oct 13, 2013
(Expired) | Concordia Pharms Inc |
| Kapvay | US5869100 | Extended release clonidine formulation (tablet) |
Oct 13, 2013
(Expired) | Concordia Pharms Inc |
Clonidine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List